- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02135575
Effects of Exercise Training on Cardiovascular Health in Middle-aged Women
August 14, 2018 updated by: Ylva Hellsten, University of Copenhagen
The hypothesis of the present study is that physical training can oppose detrimental changes in cardiovascular and metabolic health associated with estrogen loss after menopause.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark
- University of Copenhagen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 57 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Premenopausal (45-53 years) OR postmenopausal 50-57 years
- BMI> 18.5 and <30
- Sedentary (no regular physical activity the last 2 years)
- Plasma measurements
- Premenopausal: estradiol> 0.20 nmol/l, Follicle stimulating hormone < 22 IU/l and progesterone >2.5 nmol/l
- Postmenopausal: estradiol < 0.20 nmol/l, Follicle stimulating hormone > 22 IU/l and progesterone 0.3-2.5 nmol/l
Exclusion Criteria:
- Smoking
- Excessive alcohol intake
- Regular medication including hormone replacement treatment
- Chronic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Premenopausal women
The Premenopausal women are randomized to exercise by spinning (cycle)
|
After the baseline studies the pre and postmenopausal women will be randomized to spinning training groups and the intervention will last for 3 months.
The spinning group will spin three times per week under guidance of a trained instructor.
The training is heart rate monitored.
|
|
Experimental: Postmenopausal women
The Postmenopausal women are randomized to exercise by spinning (cycle)
|
After the baseline studies the pre and postmenopausal women will be randomized to spinning training groups and the intervention will last for 3 months.
The spinning group will spin three times per week under guidance of a trained instructor.
The training is heart rate monitored.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leg vascular function
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Measurements of leg blood flow by ultrasound doppler during exercise and during femoral arterial infusion of vasodilators
|
Baseline comparison and changes from baseline to 3 months
|
|
Cardiac structure and function
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Magnetic resonance imaging and transthoracic echocardiography
|
Baseline comparison and changes from baseline to 3 months
|
|
Platelet function
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Platelet aggregation assay of whole blood and platelet rich plasma
|
Baseline comparison and changes from baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expression of proteins in muscle samples
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Western Blot analysis of proteins of relevance for vascular function and metabolism
|
Baseline comparison and changes from baseline to 3 months
|
|
Maximal aerobic effect
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Maximal oxygen uptake during an incremental cycle ergometry test with gas analysis
|
Baseline comparison and changes from baseline to 3 months
|
|
Genomic profile in blood samples
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Genomic analysis of parameters for vascular and metabolic health
|
Baseline comparison and changes from baseline to 3 months
|
|
Insulin sensitivity and glycaemic control
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Fasting plasma glucose analysis and oral glucose tolerance test
|
Baseline comparison and changes from baseline to 3 months
|
|
Arterial blood pressure
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Baseline comparison and changes from baseline to 3 months
|
|
|
Gene expression of proteins in muscle samples
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Gene analysis of relevance for vascular and metabolic function
|
Baseline comparison and changes from baseline to 3 months
|
|
Health related parameters in blood
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Plasma lipid status and other variables related to vascular health
|
Baseline comparison and changes from baseline to 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anthropometry
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Dual x-ray absorptiometry, height, weight, waist and hip circumference
|
Baseline comparison and changes from baseline to 3 months
|
|
Activity measure
Time Frame: Baseline comparison and changes from baseline to 3 months
|
Activity measure for one week by accelerometer
|
Baseline comparison and changes from baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erik Richter, MD PhD, University of Copenhagen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
April 1, 2014
First Submitted That Met QC Criteria
May 6, 2014
First Posted (Estimate)
May 12, 2014
Study Record Updates
Last Update Posted (Actual)
August 16, 2018
Last Update Submitted That Met QC Criteria
August 14, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CWS-WP2CV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Spinning
-
Premier HealthDartmouth-Hitchcock Medical Center; Parkinson's Disease FoundationCompletedParkinson DiseaseUnited States
-
Poznan University of Physical EducationPoznan University of Medical SciencesCompletedHypertension | Obesity | Dyslipidemias | Type 2 Diabetes | Endothelial DysfunctionPoland
-
Somogy Megyei Kaposi Mór Teaching HospitalCompletedMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Primary ProgressiveHungary
-
University of CopenhagenRigshospitalet, Denmark; Glostrup University Hospital, CopenhagenCompletedInsulin Resistance | Menopause | Body Composition, BeneficialDenmark
-
Dartmouth-Hitchcock Medical CenterParkinson's Disease FoundationTerminatedParkinson's DiseaseUnited States
-
University Hospital, Strasbourg, FranceUnknown